Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: XYL stock price vs TT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TT's multiple
Needs TT P/E.
Implied fair value · at XYL's multiple
Needs XYL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Xylem Inc. · implied price per share
Bear
$36.50
Base
$43.66
Bull
$52.98
TRANE TECHNOLOGIES PLC · implied price per share
Bear
$125.61
Base
$149.98
Bull
$181.70
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
DANAHER CORP /DE/
XYL vs DHR
IDEX CORP /DE/
XYL vs IEX
PENTAIR plc
XYL vs PNR
ECOLAB INC.
XYL vs ECL
FLOWSERVE CORP
XYL vs FLS
DOVER Corp
XYL vs DOV
HONEYWELL INTERNATIONAL INC
XYL vs HON
LENNOX INTERNATIONAL INC
XYL vs LII
Johnson Controls International plc
XYL vs JCI
Walt Disney Co
XYL vs DIS
EMERSON ELECTRIC CO
XYL vs EMR
SPX Technologies, Inc.
XYL vs SPXC
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe XYL can narrow its profitability and ROIC gap versus TT while sustaining mid-single-digit growth, then buying XYL is reasonable because it already trades at lower P/E, P/S, EV/EBITDA, and EV/Revenue multiples than TT.
XYL is cheaper than TT on every provided valuation multiple, including P/E, P/S, EV/EBITDA, and EV/Revenue, which supports a relative discount argument. However, the market is still assigning XYL a valuation above the low end of its historical range, while the DCF range is far below the current price, creating a wide spread in fair-value signals.
Supporting Metrics
